Finlay Vaccine Institute director, Dr. Vicente Vérez Bencomo, reports that Cuba is creating capacity to produce 100 million doses of the Soberana 02 vaccine

Soberana 02 clinical trials expanded. First steps for participating volunteers include signing an informed consent document and evaluation by medical staff